FindTrial
Sign In

Pharmacogenetic Reseach of Alcolhol Liver Disease

Influence of Metabolic Enzyme Gene Polymorphisms on Alcoholic Liver Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-15006899
Enrollment
Unknown
Registered
2015-08-09
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholic Liver Disease

Interventions

Alcohol liver disease group:liver-protecting therapy
non alcohol liver disease group:No intervention

Sponsors

Institute of Clinical Pharmacology, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients confirm with alcohol liver disease

Exclusion criteria

Exclusion criteria: Patients with hepatitis virus A, B, C, D and E, drug abuse and other diseases, such as cold, diarrhea, cholecystitis, bleeding, primary and secondary liver tumors, cardiac insufficiency and congenital liver disease.

Design outcomes

Primary

MeasureTime frame
liver ultrasound;—

Secondary

MeasureTime frame
liver function;—

Countries

China

Contacts

Public ContactYao Chen
cbohua@163.com+86 13787221049

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026